{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:29:55Z","timestamp":1761092995228,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.urolonc.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T11:30:36Z","timestamp":1386847836000},"page":"426-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Expression patterns of candidate susceptibility genes HNF1\u03b2 and CtBP2 in prostate cancer: Association with tumor progression"],"prefix":"10.1016","volume":"32","author":[{"given":"Celine","family":"Debiais-Delpech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Godet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois-Xavier","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Irani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Cathelineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Cussenot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaelle","family":"Fromont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.09.006_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pros.21235","article-title":"Meta-analysis of genome-wide and replication association studies on prostate cancer","volume":"71","author":"Liu","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.09.006_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.91","article-title":"Multiple loci identified in a genome-wide association study of prostate cancer","volume":"40","author":"Thomas","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2013.09.006_bib3","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1158\/1055-9965.EPI-08-1142","article-title":"Generalizability of associations from prostate cancer GWAS in multiple populations","volume":"18","author":"Waters","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2013.09.006_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/ng.214","article-title":"Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12","volume":"40","author":"Sun","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2013.09.006_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.90","article-title":"Multiple newly identified loci associated with prostate cancer susceptibility","volume":"40","author":"Eeles","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2013.09.006_bib6","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1073\/pnas.1200853109","article-title":"Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis","volume":"109","author":"Grisanzio","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2013.09.006_bib7","doi-asserted-by":"crossref","first-page":"e13363","DOI":"10.1371\/journal.pone.0013363","article-title":"The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine","volume":"5","author":"Whitaker","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2013.09.006_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/pros.22485","article-title":"BCAR1 expression improves prediction of biochemical reccurence after radical prostatectomy","volume":"72","author":"Fromont","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.09.006_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2013.01.012","article-title":"8q24 amplification is associated with MYC expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy","author":"Fromont","year":"2013","journal-title":"Human Pathol"},{"key":"10.1016\/j.urolonc.2013.09.006_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/1078-0432.CCR-10-0881","article-title":"Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence","volume":"17","author":"Ahn","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2013.09.006_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pros.22532","article-title":"Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1536 GWAS and candidate SNPs in African-Americans and European-Americans","volume":"73","author":"Bensen","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.09.006_bib12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/pros.21149","article-title":"A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression","volume":"70","author":"Xu","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.09.006_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2010.238","article-title":"Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis","volume":"24","author":"Dahlman","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2013.09.006_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/pcan.2010.25","article-title":"Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3","volume":"13","author":"Dahlman","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2013.09.006_bib15","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1158\/0008-5472.CAN-04-0788","article-title":"A synthetic 15-mer Peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia","volume":"64","author":"Shukeir","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.09.006_bib16","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/ijc.21615","article-title":"A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis","volume":"118","author":"Lamy","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2013.09.006_bib17","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0002-9440(10)63605-X","article-title":"Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1\u03b2 as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma","volume":"163","author":"Tsuchiya","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2013.09.006_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/1471-2407-10-315","article-title":"Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer","volume":"10","author":"Harries","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2013.09.006_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbaexp.2005.10.003","article-title":"Identification of target genes of the transcription factor HNF1\u03b2 and HNF1\u03b1 in a human embryonic kidney cell line","volume":"1731","author":"Senkel","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.urolonc.2013.09.006_bib20","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1158\/1078-0432.CCR-08-0870","article-title":"Activation of the osteopontin\/matrix metalloproteinase-9 pathway correlates with prostate cancer progression","volume":"14","author":"Castellano","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2013.09.006_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1158\/0008-5472.CAN-08-3349","article-title":"The transcriptional corepressor CtBP: a foe of multiple tumor suppressors","volume":"69","author":"Chinnadurai","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.09.006_bib22","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.4161\/cc.9.18.12936","article-title":"Therapeutic targeting of C-terminal binding protein in human cancer","volume":"9","author":"Straza","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.urolonc.2013.09.006_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BC20100067","article-title":"Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance","volume":"103","author":"Birts","year":"2011","journal-title":"Biol Cell"},{"key":"10.1016\/j.urolonc.2013.09.006_bib24","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1128\/MCB.02402-05","article-title":"Mechanisms directing the nuclear localization of the CtBP family proteins","volume":"26","author":"Verger","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2013.09.006_bib25","first-page":"481","article-title":"CtBP2 promotes human cancer cell migration by transcriptional activation of Tiam1","volume":"3","author":"Paliwal","year":"2012","journal-title":"Genes and Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913003499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913003499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:20Z","timestamp":1761040880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913003499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1078143913003499"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.09.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression patterns of candidate susceptibility genes HNF1\u03b2 and CtBP2 in prostate cancer: Association with tumor progression","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}